Bone Biology Laboratory http://www.iupui.edu/~bonelab/ Department of Anatomy and Cell Biology Indiana University School of Medicine Department of Biomedical Engineering IUPUIRaloxifene treatment has been shown previously to positively affect bone mechanical properties following one year of treatment in skeletally mature dogs. Reference point indentation (RPI) can be used for in vivo assessment of mechanical properties and has been shown to produce values that are highly correlated with properties derived from traditional mechanical testing. The goal of this study was to use RPI to determine if raloxifene-induced alterations in mechanical properties occurred after 6 months of treatment. Twelve skeletally mature female beagle dogs were tre...
The OsteoProbe is a second-generation reference point indentation (RPI) device without a reference p...
AbstractThe OsteoProbe is a second-generation reference point indentation (RPI) device without a ref...
Raloxifene hydrochloride therapy effectiveness in bone mineral density (BMD) changes compared to cal...
We have previously documented that raloxifene enhances the mechanical properties of dog vertebrae in...
Raloxifene positively affects mechanical properties of the bone matrix in part through modification ...
Anti-remodeling agents produce similar reductions in vertebral fracture risk despite large differenc...
A growing number of studies have investigated combination treatment as an approach to treat bone dis...
Osteogenesis imperfecta (OI) is a genetic disease of Type I collagen and collagen-associated pathway...
Osteoporosis is defined as a decrease of bone mass and strength, as well as an increase in fracture ...
Abstract Background Failure of surgical fixation in o...
Pre-clinical data have shown that tissue level effects stemming from bisphosphonateinduced suppressi...
Bisphosphonates represent the gold-standard pharmaceutical agent for reducing fracture risk. Long-te...
Raloxifene is an FDA-approved selective estrogen receptor modulator (SERM) that improves tissue qual...
Raloxifene (RAL) is an FDA-approved drug used to treat osteoporosis in postmenopausal women. RAL sup...
Bone Biology Laboratory [LINK]http://www.iupui.edu/~bonelab[/LINK]Reference point indentation (RPI) ...
The OsteoProbe is a second-generation reference point indentation (RPI) device without a reference p...
AbstractThe OsteoProbe is a second-generation reference point indentation (RPI) device without a ref...
Raloxifene hydrochloride therapy effectiveness in bone mineral density (BMD) changes compared to cal...
We have previously documented that raloxifene enhances the mechanical properties of dog vertebrae in...
Raloxifene positively affects mechanical properties of the bone matrix in part through modification ...
Anti-remodeling agents produce similar reductions in vertebral fracture risk despite large differenc...
A growing number of studies have investigated combination treatment as an approach to treat bone dis...
Osteogenesis imperfecta (OI) is a genetic disease of Type I collagen and collagen-associated pathway...
Osteoporosis is defined as a decrease of bone mass and strength, as well as an increase in fracture ...
Abstract Background Failure of surgical fixation in o...
Pre-clinical data have shown that tissue level effects stemming from bisphosphonateinduced suppressi...
Bisphosphonates represent the gold-standard pharmaceutical agent for reducing fracture risk. Long-te...
Raloxifene is an FDA-approved selective estrogen receptor modulator (SERM) that improves tissue qual...
Raloxifene (RAL) is an FDA-approved drug used to treat osteoporosis in postmenopausal women. RAL sup...
Bone Biology Laboratory [LINK]http://www.iupui.edu/~bonelab[/LINK]Reference point indentation (RPI) ...
The OsteoProbe is a second-generation reference point indentation (RPI) device without a reference p...
AbstractThe OsteoProbe is a second-generation reference point indentation (RPI) device without a ref...
Raloxifene hydrochloride therapy effectiveness in bone mineral density (BMD) changes compared to cal...